Live feed
Filing
SC 13G
SC 13G0001085146-22-000291·Cowen Financial Products LLC
Schedule 13G ownership disclosure
Stoke Therapeutics Inc
Security class unavailable · CUSIP: 86150R107
Event date: 2022-01-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,871,529
- Percent of class
- 5.0900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-22-000291
- Form type
- SC 13G
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Jan 24, 2022
- Reporting period
- Jan 19, 2022
- Description
- Schedule 13G beneficial ownership